All Stories

  1. Stillbirths at 22- and 28-weeks’ gestation or longer for the states in India: findings from the Global Burden of Disease Study 2023
  2. Virus reactivation in acute and long COVID-19
  3. Mapping drivers of life expectancy change in Asia from 1990 to 2023
  4. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  5. Global, regional, and national burden of road injuries 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  6. Early immune events during SARS-CoV-2 infection impact memory T and B cell responses
  7. Burden of cancer attributable to occupational asbestos exposure in the Americas, 1990–2023: an analysis using the Global Burden of Disease Study 2023
  8. Global burden of enteric infectious diseases, diarrhoeal diseases, and corresponding aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  9. Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990–2023: a Global Burden of Disease study
  10. Global burden of adverse effects of medical treatment from 1990 to 2021: a Global Burden of Disease Study 2021
  11. Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  12. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
  13. Quantifying the fatal and non-fatal burden of disease associated with child growth failure, 2000–2023: a systematic analysis from the Global Burden of Disease Study 2023
  14. Unearthing soil biodiversity through collaborative genomic research and education
  15. Disease burden attributable to intimate partner violence against females and sexual violence against children in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  16. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  17. Global, regional, and national burden of Chagas disease, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  18. Type 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort
  19. Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS
  20. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  21. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  22. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023
  23. Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  24. Burden of neurological disorders in China and its provinces, 1990–2021: Findings from the global burden of disease study 2021
  25. Proceedings of the 6th National Big Data Health Science Conference
  26. Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC study
  27. Global burden of vision impairment due to age-related macular degeneration, 1990–2021, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  28. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  29. Prevalence of Vision Loss in Latin America and the Caribbean in 2020: Magnitude and Temporal Trends
  30. High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19
  31. Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 Mortality
  32. Prevalence of Vision Loss in High-Income Countries and in Eastern and Central Europe in 2020: Magnitude and Temporal Trends
  33. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  34. Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study
  35. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  36. An Allele of the MTHFR one-carbon metabolism gene predicts severity of COVID-19
  37. Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  38. Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
  39. Identification of a multi-omics factor predictive of long COVID in the IMPACC study
  40. Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors
  41. Global, regional, and national burden of suicide, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  42. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
  43. Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients
  44. Evaluating Differences in Small Object Localization Using Semantic Segmentation and Single Shot Detector (SSD) Bounding Box Algorithm
  45. Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019
  46. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
  47. The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000–2021: a systematic analysis for the Global Burden of Disease Study 2021
  48. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
  49. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  50. The Global Burden of Diarrheal Diseases: Causes, Risks, and Trends (1990–2021)
  51. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  52. Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular Subtyping
  53. Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19
  54. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
  55. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  56. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  57. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
  58. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  59. Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  60. OpenAI's GPT-3/ChatGPT: Suggests & Correct
  61. Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
  62. Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020
  63. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020
  64. Global pattern, trend, and cross-country inequality of early musculoskeletal disorders from 1990 to 2019, with projection from 2020 to 2050
  65. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a syst...
  66. Burden of disease scenarios for 204 countries
  67. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  68. Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology
  69. A supervised Bayesian factor model for the identification of multi-omics signatures
  70. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
  71. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  72. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  73. Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  74. TB Trends and WHO Goals: Global Age-Specific Analysis 1990-2021
  75. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study
  76. Addressing Class Imbalance Problem in Semantic Segmentation Using Binary Focal Loss
  77. Stroke Risk Stratification Using Neural Networks
  78. Global Burden of Cardiovascular Diseases and Risks, 1990-2022
  79. Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants
  80. Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000–2021: results from the Global Burden of Disease Study 2021
  81. Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  82. Global, regional, and national burden of other musculoskeletal disorders, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  83. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
  84. Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  85. Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients
  86. Hearing Loss Prevalence, Years Lived With Disability, and Hearing Aid Use in the United States From 1990 to 2019: Findings From the Global Burden of Disease Study
  87. Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
  88. Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  89. The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis
  90. Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
  91. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
  92. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition
  93. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  94. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients
  95. Potential use of endemic human coronaviruses to stimulate immunity against pathogenic SARS-CoV-2 and its variants
  96. Data from Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
  97. Data from Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
  98. Supplementary Figure from Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
  99. Supplementary Figure from Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
  100. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026
  101. A supervised Bayesian factor model for the identification of multi-omics signatures
  102. K-fold Semi-supervised Self-learning Technique for Image Disease Localization
  103. Cyclical Learning Rates (CLR’S) for Improving Training Accuracies and Lowering Computational Cost
  104. Neural Networks for Predicting Severity of Ovarian Carcinomas
  105. Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000–2018
  106. Assessing performance of the Healthcare Access and Quality Index, overall and by select age groups, for 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  107. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  108. Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019
  109. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019
  110. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019
  111. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study
  112. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  113. Probiotics: insights and new opportunities for Clostridioides difficile intervention
  114. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status
  115. Evaluating Performance of Regression and Classification Models Using Known Lung Carcinomas Prognostic Markers
  116. Proceedings of Sixth International Congress on Information and Communication Technology
  117. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
  118. Cyclical Learning Rates (CLR’s) for Improving Training Accuracies and Lowering Computational Cost
  119. Extracellular calcium alters calcium-sensing receptor network integrating intracellular calcium-signaling and related key pathway
  120. Tracking development assistance for health and for COVID-19
  121. Global, regional, and national sex-specific burden and control of the HIV epidemic
  122. Fatal police violence by race and state in the USA, 1980–2019: a network meta-regression
  123. Single shot detector application for image disease localization
  124. Child Mortality Trends and Targets: GBD 2019 Findings
  125. Measuring routine childhood vaccination coverage in 204 countries and territories
  126. LinkedImm: a linked data graph database for integrating immunological data
  127. G protein-coupled receptors as candidates for modulation and activation of the chemical senses in decapod crustaceans
  128. Subnational mapping of HIV incidence and mortality among individuals aged 15–49 years in sub-Saharan Africa, 2000–18: a modelling study
  129. Current clinical trials and patent update on lung cancer: a retrospective review
  130. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  131. RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice
  132. Machine learning for identification and characterization of molecular gene signatures in progression of benign tumors
  133. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
  134. Hemoglobin Induces Early and Robust Biofilm Development in Streptococcus pneumoniae by a Pathway That Involves comC but Not the Cognate comDE Two-Component System
  135. Hearing loss prevalence and years lived with disability
  136. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
  137. Mapping subnational HIV mortality in six Latin American countries with incomplete vital registration systems
  138. Sustainable Intelligent Systems
  139. Bioinformatics Algorithms and Software for Predicting Microbiomes
  140. Hemoglobin stimulates vigorous growth of Streptococcus pneumoniae and shapes the pathogen's global transcriptome
  141. Scalable, Reliable and Robust Data Mining Infrastructures
  142. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence
  143. DNA Encoded Glycan Libraries as a next-generation tool for the study of glycan-protein interactions
  144. Effects of temperature on COVID-19 transmission
  145. Comparison of transcriptomes from two chemosensory organs in four decapod crustaceans reveals hundreds of candidate chemoreceptor proteins
  146. Clustering Reveals Common Check-Point and Growth Factor Receptor Genes Expressed in Six Different Cancer Types
  147. Addendum
  148. Abstract 4247: Predicting the prognosis for cancer patients with interleukins gene expression level
  149. Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant Acinetobacter baumannii
  150. Structural studies of antiviral inhibitor with HIV-1 protease bearing drug resistant substitutions of V32I, I47V and V82I
  151. Genome Sequence of Bordetella pertussis Vaccine Strain BP 165
  152. A Six-Gene-Based Prognostic Model Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients
  153. Curcumin in combination with anti-cancer drugs: A nanomedicine review
  154. Current clinical trials update on HIV/AIDS: a systematic review
  155. Developing a DEVS-JAVA Model to Simulate and Pre-test Changes to Emergency Care Delivery in a Safe and Efficient Manner
  156. Web-Based Application for Accurately Classifying Cancer Type from Microarray Gene Expression Data Using a Support Vector Machine (SVM) Learning Algorithm
  157. Transcriptomic data for analyzing global gene expression patterns in Methicillin-resistance Staphylococcus aureus in response to spermine and oxacillin stress
  158. Analysis of drug resistance in HIV protease
  159. Spermine and oxacillin stress response on the cell wall synthesis and the global gene expression analysis in Methicillin-resistance Staphylococcus aureus
  160. RodentSQL: a software suite for colony management of animal protocols
  161. In silico Identification of the Indispensable Quorum Sensing Proteins of Multidrug Resistant Proteus mirabilis
  162. A side-effect free method for identifying cancer drug targets
  163. Evaluation of centrosome clustering protein KIFC1 as a potential prognostic biomarker in serous ovarian adenocarcinomas.
  164. A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
  165. Interactome analyses of Salmonella pathogenicity islands reveal SicA indispensable for virulence
  166. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
  167. Statistical analysis of microarray gene expression data from a mouse model of toxoplasmosis